Missing Protein Linked to Accelerated Aging of Immune System

A recent study from the University of Illinois Chicago reveals that a decline in a specific protein may significantly impact the aging of the immune system. Researchers found that the protein, known as platelet factor 4, decreases over time, leading to an increase in blood stem cell proliferation that can result in harmful mutations. This discovery suggests a potential target for addressing age-related health issues linked to the immune system.

As people age, their immune systems become less effective, and this study identifies platelet factor 4 as a key player in this process. The findings were published on December 31, 2025, in the journal Blood. The research team observed that restoring this protein in older mice and in human stem cells significantly improved the behavior of aging blood and immune cells, effectively making them function more like those found in younger individuals.

Understanding Blood Stem Cells and Their Role

Blood stem cells, or hematopoietic stem cells, reside in the bone marrow and are vital for producing all major blood and immune cells. These include red blood cells, which transport oxygen, and lymphoid cells, such as T and B cells, which are essential for immune defense. Sandra Pinho, an associate professor of pharmacology and regenerative medicine at UIC, emphasized the importance of these stem cells, referring to them as the “Holy Grail of the immune system.”

In younger individuals, blood stem cells maintain a healthy balance between myeloid and lymphoid cell production. However, as the body ages, this balance shifts. Older blood stem cells tend to produce more myeloid cells while generating fewer lymphoid cells, leading to a weakened immune response. “That’s one of the reasons why older individuals are not typically considered as donors for bone marrow transplantation,” Pinho explained. This imbalance not only compromises immunity but also increases susceptibility to age-related diseases.

The Role of Platelet Factor 4 in Stem Cell Regulation

The research team conducted studies involving both mice and human bone marrow samples, revealing that platelet factor 4 plays a critical role in regulating the behavior of blood stem cells. In younger organisms, this protein acts as a signaling molecule that limits the frequency of stem cell division, which is particularly important for those producing myeloid cells. As the immune system ages, the production of platelet factor 4 diminishes, leading to unchecked stem cell proliferation.

“When stem cells divide more than they should and lose regulation, they can accumulate mutations over time,” Pinho noted. In humans, these mutations have been associated with chronic inflammation, increased risk of blood cancers, and cardiovascular diseases.

In a remarkable turnaround, the research team demonstrated that restoring platelet factor 4 could mitigate these age-related changes. Older mice received daily blood infusions of the protein for over a month. Following treatment, their blood and immune cells exhibited characteristics typical of much younger animals. Similarly, laboratory experiments with aged human stem cells showed marked improvements in function upon the addition of the protein.

While the results are encouraging, experts caution against expecting platelet factor 4 to reverse aging across the entire body or significantly extend human lifespan. Pinho clarified that although the effects are substantial, this protein alone will not serve as a universal solution for aging tissues. Instead, it could be integrated into broader therapeutic strategies aimed at enhancing health in older populations.

“This research provides clear evidence that it is possible to reverse certain age-associated disorders at a cellular level,” Pinho stated. The study’s first author, Sen Zhang, along with co-lead Constantinos Chronis from the Department of Biochemistry and Molecular Genetics, contributed significantly to these findings. Additional contributors included Charles Ayemoba, Anna Di Staulo, Kenneth Joves, Chandani Patel, Eva Leung, Maura Bueno, Xiaoping Du, and Sang-Ging Ong from UIC.

As the implications of this research unfold, it may pave the way for new approaches to tackle age-related disorders, potentially offering hope for healthier aging in future generations.